<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">46840</article-id><article-id pub-id-type="doi">10.7554/eLife.46840</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>Heparan sulfates are critical regulators of the inhibitory megakaryocyte-platelet receptor G6b-B</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-134519"><name><surname>Vögtle</surname><given-names>Timo</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9400-4701</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-135055"><name><surname>Sharma</surname><given-names>Sumana</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-135056"><name><surname>Mori</surname><given-names>Jun</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6212-1604</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-135057"><name><surname>Nagy</surname><given-names>Zoltan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-135058"><name><surname>Semeniak</surname><given-names>Daniela</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-150785"><name><surname>Scandola</surname><given-names>Cyril</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-135059"><name><surname>Geer</surname><given-names>Mitchell J</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-135060"><name><surname>Smith</surname><given-names>Christopher W</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-135063"><name><surname>Lane</surname><given-names>Jordan</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-135064"><name><surname>Pollack</surname><given-names>Scott</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-135070"><name><surname>Lassila</surname><given-names>Riitta</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-135071"><name><surname>Jouppila</surname><given-names>Annukka</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf5"/></contrib><contrib contrib-type="author" id="author-135072"><name><surname>Barr</surname><given-names>Alastair J</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7738-8419</contrib-id><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-135073"><name><surname>Ogg</surname><given-names>Derek J</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7751-5913</contrib-id><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="conf6"/></contrib><contrib contrib-type="author" id="author-135074"><name><surname>Howard</surname><given-names>Tina D</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="conf7"/></contrib><contrib contrib-type="author" id="author-135075"><name><surname>McMiken</surname><given-names>Helen J</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="conf8"/></contrib><contrib contrib-type="author" id="author-135076"><name><surname>Warwicker</surname><given-names>Juli</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="conf9"/></contrib><contrib contrib-type="author" id="author-135077"><name><surname>Geh</surname><given-names>Catherine</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="conf10"/></contrib><contrib contrib-type="author" id="author-135078"><name><surname>Rowlinson</surname><given-names>Rachel</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="conf11"/></contrib><contrib contrib-type="author" id="author-135079"><name><surname>Abbott</surname><given-names>W Mark</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="conf12"/></contrib><contrib contrib-type="author" id="author-150786"><name><surname>Eckly</surname><given-names>Anita</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-135080"><name><surname>Schulze</surname><given-names>Harald</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-17265"><name><surname>Wright</surname><given-names>Gavin J</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0537-0863</contrib-id><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-135081"><name><surname>Mazharian</surname><given-names>Alexandra</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-135082"><name><surname>Fütterer</surname><given-names>Klaus</given-names></name><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-135083"><name><surname>Rajesh</surname><given-names>Sundaresan</given-names></name><xref ref-type="aff" rid="aff12">12</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-135084"><name><surname>Douglas</surname><given-names>Michael R</given-names></name><xref ref-type="aff" rid="aff13">13</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-134536"><name><surname>Senis</surname><given-names>Yotis A</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0947-9957</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Institute of Cardiovascular Sciences</institution>, <institution>University of Birmingham</institution>, <addr-line><named-content content-type="city">Birmingham</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff2"><institution content-type="dept">Cell Surface Signalling Laboratory</institution>, <institution>Wellcome Sanger Institute</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff3"><institution content-type="dept">Institute of Experimental Biomedicine</institution>, <institution>University Hospital Würzburg</institution>, <addr-line><named-content content-type="city">Würzburg</named-content></addr-line>, <country>Germany</country></aff><aff id="aff4"><institution content-type="dept">Institut National de la Santé et de la Recherche Médicale, Etablissement Français du Sang Grand Est</institution>, <institution>Université de Strasbourg</institution>, <addr-line><named-content content-type="city">Strasbourg</named-content></addr-line>, <country>France</country></aff><aff id="aff5"><institution>Sygnature Discovery Limited</institution>, <addr-line><named-content content-type="city">Nottingham</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff6"><institution content-type="dept">Coagulation Disorders Unit</institution>, <institution>University of Helsinki</institution>, <addr-line><named-content content-type="city">Helsinki</named-content></addr-line>, <country>Finland</country></aff><aff id="aff7"><institution content-type="dept">Coagulation Disorders Unit</institution>, <institution>Helsinki University Hospital Research Institute</institution>, <addr-line><named-content content-type="city">Helsinki</named-content></addr-line>, <country>Finland</country></aff><aff id="aff8"><institution content-type="dept">Department of Biomedical Science</institution>, <institution>University of Westminster</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff9"><institution>Peak Proteins Limited</institution>, <addr-line><named-content content-type="city">Alderley Park</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff10"><institution content-type="dept">Cell Surface Signalling Laboratory</institution>, <institution>Wellcome Trust Sanger Institute</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff11"><institution content-type="dept">School of Biosciences</institution>, <institution>University of Birmingham</institution>, <addr-line><named-content content-type="city">Birmingham</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff12"><institution content-type="dept">Institute of Cancer and Genomic Sciences</institution>, <institution>University of Birmingham</institution>, <addr-line><named-content content-type="city">Birmingham</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff13"><institution content-type="dept">Institute of Inflammation and Ageing</institution>, <institution>University of Birmingham</institution>, <addr-line><named-content content-type="city">Birmingham</named-content></addr-line>, <country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-39433"><name><surname>Bjorkman</surname><given-names>Pamela J</given-names></name><role>Reviewing editor</role><aff><institution>California Institute of Technology</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>y.senis@bham.ac.uk</email> (YS);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>22</day><month>08</month><year>2019</year></pub-date><volume>8</volume><elocation-id>e46840</elocation-id><history><date date-type="received"><day>14</day><month>03</month><year>2019</year></date><date date-type="accepted"><day>21</day><month>08</month><year>2019</year></date></history><permissions><copyright-statement>© 2019, Vögtle et al</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Vögtle et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-46840-v1.pdf"/><abstract><p>The immunoreceptor tyrosine-based inhibition motif (ITIM)-containing receptor G6b-B is critical for platelet production and activation. Loss of G6b-B results in severe macrothrombocytopenia, myelofibrosis and aberrant platelet function in mice and humans. Using a combination of immunohistochemistry, affinity chromatography and proteomics, we identified the extracellular matrix heparan sulfate (HS) proteoglycan perlecan as a G6b-B binding partner. Subsequent <italic>in vitro</italic> biochemical studies and a cell-based genetic screen demonstrated that the interaction is specifically mediated by the HS chains of perlecan. Biophysical analysis revealed that heparin forms a high-affinity complex with G6b-B and mediates dimerization. Using platelets from humans and genetically-modified mice, we demonstrate that binding of G6b-B to HS and multivalent heparin inhibits platelet and megakaryocyte function by inducing downstream signaling via the tyrosine phosphatases Shp1 and Shp2. Our findings provide novel insights into how G6b-B is regulated and contribute to our understanding of the interaction of megakaryocytes and platelets with glycans.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000274</institution-id><institution>British Heart Foundation</institution></institution-wrap></funding-source><award-id>RG/15/13/31673</award-id><principal-award-recipient><name><surname>Mori</surname><given-names>Jun</given-names></name><name><surname>Mazharian</surname><given-names>Alexandra</given-names></name><name><surname>Senis</surname><given-names>Yotis A</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000274</institution-id><institution>British Heart Foundation</institution></institution-wrap></funding-source><award-id>FS/13/1/29894</award-id><principal-award-recipient><name><surname>Senis</surname><given-names>Yotis A</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>VO 2134-1/1</award-id><principal-award-recipient><name><surname>Vögtle</surname><given-names>Timo</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>Confidence in Concept 2018</award-id><principal-award-recipient><name><surname>Vögtle</surname><given-names>Timo</given-names></name><name><surname>Senis</surname><given-names>Yotis A</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome</institution></institution-wrap></funding-source><award-id>206194</award-id><principal-award-recipient><name><surname>Wright</surname><given-names>Gavin J</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000274</institution-id><institution>British Heart Foundation</institution></institution-wrap></funding-source><award-id>FS/15/58/31784</award-id><principal-award-recipient><name><surname>Mazharian</surname><given-names>Alexandra</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Jordan Lane, at the time of the study, was employee at Sygnature Discovery Limited, performing surface plasmon resonance experiments as part of a paid service.</p></fn><fn fn-type="conflict" id="conf3"><p>Scott Pollack, is employee at Sygnature Discovery Limited, performing surface plasmon resonance experiments as part of a paid service.</p></fn><fn fn-type="conflict" id="conf4"><p>Riitta Lassila, is CSO and shareholder of Aplagon Oy, Helsinki, Finland.</p></fn><fn fn-type="conflict" id="conf5"><p>Annukka Jouppila, receives research funding from Aplagon Oy, Helsinki, Finland.</p></fn><fn fn-type="conflict" id="conf6"><p>Derek J Ogg, is employee at Peak proteins Limited, performing crystallography and protein expression studies as part of a paid service.</p></fn><fn fn-type="conflict" id="conf7"><p>Tina D Howard, is employee at Peak proteins Limited, performing crystallography and protein expression studies as part of a paid service.</p></fn><fn fn-type="conflict" id="conf8"><p>Helen J McMiken, is employee at Peak proteins Limited, performing crystallography and protein expression studies as part of a paid service.</p></fn><fn fn-type="conflict" id="conf9"><p>Juli Warwicker, is employee at Peak proteins Limited, performing crystallography and protein expression studies as part of a paid service.</p></fn><fn fn-type="conflict" id="conf10"><p>Catherine Geh, is employee at Peak proteins Limited, performing crystallography and protein expression studies as part of a paid service.</p></fn><fn fn-type="conflict" id="conf11"><p>Rachel Rowlinson, is employee at Peak proteins Limited, performing crystallography and protein expression studies as part of a paid service.</p></fn><fn fn-type="conflict" id="conf12"><p>W Mark Abbott, is CEO of Peak proteins Limited, performing crystallography and protein expression studies as part of a paid service.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All animal procedures were undertaken with the U.K. Home Office approval (project license No P46252127) in accordance with the Animals (Scientific Procedures) Act of 1986.</p></fn><fn fn-type="other"><p>Human subjects: Blood was collected from healthy drug-free volunteers.  Donors gave full informed consent according to the Helsinki declaration.  Ethical approval for collecting blood was granted by Birmingham University Internal Ethical Review (ERN_11-0175 and ERN_15-0973).</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Diffraction data have been deposited in PDB under the accession code 6R0X</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Vögtle et al</collab></person-group><year iso-8601-date="2019">2019</year><source>G6b-B in complex with dp12</source><ext-link ext-link-type="uri" xlink:href="http://www.rcsb.org/structure/6R0X">http://www.rcsb.org/structure/6R0X</ext-link><comment>Protein Data Bank, 6R0X</comment></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation id="dataset2" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Cai Z</collab><collab>Yarovoi S V</collab><collab>Zhu Z</collab><collab>Rauova L</collab><collab>Hayes V</collab><collab>Lebedeva T</collab><collab>Liu Q</collab><collab>Poncz M</collab><collab>Arepally G</collab><collab>Cines D B</collab><collab>Greene M I</collab></person-group><year iso-8601-date="2015">2015</year><source>Crystal structure of platelet factor 4 complexed with fondaparinux</source><ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/structure/4R9W">https://www.rcsb.org/structure/4R9W</ext-link><comment>Protein Data Bank, 4R9W</comment></element-citation><element-citation id="dataset3" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Dahms S O</collab><collab>Mayer M C</collab><collab>Roeser D</collab><collab>Multhaup G</collab><collab>Than M E</collab></person-group><year iso-8601-date="2015">2015</year><source>X-RAY STRUCTURE OF THE AMYLOID PRECURSOR PROTEIN-LIKE PROTEIN 1 (APLP1) E2 DOMAIN IN COMPLEX WITH A HEPARIN DODECASACCHARIDE</source><ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/structure/4RDA">https://www.rcsb.org/structure/4RDA</ext-link><comment>Protein Data Bank, 4RDA</comment></element-citation><element-citation id="dataset4" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Fukuhara N</collab><collab>Howitt J A</collab><collab>Hussain S A</collab><collab>Hohenester E</collab></person-group><year iso-8601-date="2008">2008</year><source>Drosophila Robo IG1-2 (monoclinic form)</source><ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/structure/2VRA">https://www.rcsb.org/structure/2VRA</ext-link><comment>Protein Data Bank, 2VRA</comment></element-citation><element-citation id="dataset5" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Pellegrini L</collab><collab>Burke D F</collab><collab>von Delft F</collab><collab>Mulloy B</collab><collab>Blundell T L</collab></person-group><year iso-8601-date="2000">2000</year><source>CRYSTAL STRUCTURE OF A TERNARY FGF1-FGFR2-HEPARIN COMPLEX</source><ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/structure/1E0O">https://www.rcsb.org/structure/1E0O</ext-link><comment>Protein Data Bank, 1E0O</comment></element-citation><element-citation id="dataset6" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Schlessinger J</collab><collab>Plotnikov A N</collab><collab>Ibrahimi O A</collab><collab>Eliseenkova A V</collab><collab>Yeh B K</collab><collab>Yayon A</collab><collab>Linhardt R J</collab><collab>Mohammadi M</collab></person-group><year iso-8601-date="2000">2000</year><source>CRYSTAL STRUCTURE OF A TERNARY FGF2-FGFR1-HEPARIN COMPLEX</source><ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/structure/1FQ9">https://www.rcsb.org/structure/1FQ9</ext-link><comment>Protein Data Bank, 1FQ9</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-46840-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>